Evercore ISI Group Maintains Outperform on Abbott Laboratories, Raises Price Target to $120

Benzinga Newsdesk www.benzinga.com Positive 90.9%

Neg 0% Neu 0% Pos 90.9%

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $112 to $120.